一项针对晚期肺癌患者的研究显示，早晨时段接受免疫化疗可显著延长生存时间。香港医学专家表示，这一发现为优化治疗时机提供了可能性，但需进一步研究。该研究由湖南癌症医院主导，并获香港中文大学医学系支持。
晚期肺癌患者若在上午时段接受免疫化疗，治疗效果更佳，一项新研究揭示了这一发现。该研究针对非小细胞肺癌患者，比较了不同时段的治疗效果，结果显示，上午3点前施用免疫化疗，几乎将从治疗开始到疾病进展的时间（无进展生存期）延长了一倍，同时将中位总生存期提高了近70%。
这项随机对照研究是首次证明晨间与午后输注免疫化疗的差异，由湖南癌症医院学者主导，并在《自然医学》杂志上发表。香港中文大学临床肿瘤学系主任、研究联合通讯作者莫树锦教授于周五表示：“这一发现极具鼓舞性，仅通过简单调整治疗时机，即可提升疗效并改善生存率，而无需额外成本给患者或医疗系统带来负担。”
莫教授强调，虽然结果令人振奋，但仍需更多研究来验证和推广这一优化策略。该研究为肺癌治疗带来了新希望，尤其是在免疫疗法日益重要的背景下。
由 AI 报道 AI 生成的图像 事实核查
Researchers at McGill University report a drug-based method to temporarily enhance natural killer (NK) cells—an immune cell type—by inhibiting two proteins, improving the cells’ ability to attack several aggressive cancers in preclinical experiments.
New research from Fox Chase Cancer Center shows that melanoma spreads more aggressively in middle-aged mice than in young or very old ones. The pattern appears linked to changes in a specific type of immune cell over time.
由 AI 报道
Sequencio, a new Hong Kong unit of CK Life Sciences, is advancing about 20 cancer vaccine projects via China's faster pathway to human trials. CK Life Sciences vice-president and chief scientific officer Dr Melvin Toh Kean-meng said the firm plans investigator-initiated trials next year.
New cases of lung cancer among women in Hong Kong have increased by 20 percent over the past two decades. Experts point to genetic factors and cooking fumes as contributors alongside smoking.
由 AI 报道
A clinical trial led by Mass General Brigham researchers shows that the drug solriamfetol significantly improves wakefulness and performance for workers starting shifts before sunrise. Participants with shift work disorder stayed alert longer during simulated work hours after taking the medication. The findings address a gap in treatments for the most common type of shift schedule.